Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

*Pharmacology 5815 > 1. antipsychotics > Flashcards

1. antipsychotics Flashcards

1
Q

true or false: antipsychotics are mainly antagonists

A

true - there are some instances where they may be a partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the amino acid precursor of dopamine

A

tyrosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the two types of degrading enzymes found in the dopaminergic presynaptic axon terminal?

A

MAO and COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

true or false: MAO degrading enzymes can be found intracellularly and extracellularly

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

true or false: COMT degrading enzymes can be found intracellular and extracellularly

A

false - only extracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the purpose of the dopamine transporter (DAT) or reuptake pump?

A

Transport dopamine back up into presynaptic neuron from the synaptic cleft therefore regulating the amount of dopamine in the cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the three fates of DA in the presynaptic axon terminal?

A
  1. DA can be stored in vesicles inside the neuron
  2. If the vesicle fuses with the neurons membrane, DA can get back out into the cleft
  3. DA can be broken down by MAO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where in the synaptic cleft do drugs normally target?

A

Dopamine transporter (DAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

This regulates the release of dopamine from the presynaptic neuron

A

Presynaptic D2 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

This is a post synaptic DA receptor involved in psychosis, movement and prolactin regulation. All antipsychotics has an action on this receptor

A

D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clozapine is a potent antagonist of this post synaptic DA receptor

A

D4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 4 main DA pathways in the brain

A
  1. Nigrostriatal
  2. Mesolimbic
  3. Mesocortival
  4. Tuberoinfundinular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of symptoms occur if there is too much DA present in mesolimbic pathway

A

Positive symptoms (e.g. hallucinations, hearing voices)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What symptoms occur if there is too little DA in the mesocortical pathway?

A

dorsolateral PFC & ventromedical PFC = negative sx’s
dorsolsteral PFC = cognitive sx’s (trouble focusing, learning)
Ventromedicsl PFC = Mood symptoms (depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or false: treatment goals include increasing DA in nigrostriatal and tuberoinfundibular pathways

A

False - these pathways should be left alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of antipsychotics are the following:
Chlorpromazine, perphenazine, loxapine, zuclopenthixol, fluphenazine, trifluoperazine, haloperidol

A

1st generation or typical/conventional antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What type of antipsychotics are the following:
Risperidone, quetiapine, olanzapine, paliperidone, ziprasidone, clozapine, asenapine, lurasidone.

A

2nd generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What type of antipsychotics are the following:
Aripiprazole, brexpiprazole, cariprazine

A

3rd generation antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

First generation antipsychotics may have different affinities and potencies for blocking what four receptors?

A

D2, M1, H1 and alpha1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

If an FGA has a high potency for blocking D2, it will have inverse affinities for blocking M1, H1 and alpha1

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What will happen if you add a D2 antagonist when there is too much dopamine in the mesolimbic tract

A

Decrease positive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What will happen if you add a D2 antagonist when there is too little dopamine in the mesocortical pathway

A

May aggravate negative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What will happen if you add a D2 antagonist that affects the nigrostriatal pathway

A

Cause motor side effects (EPS)

24
Q

What will happen if you add a D2 antagonist that affects the tuberoinfundibular pathway

A

Increase prolactin release which can cause galatorrhea or amenorrhea

25
Q

What type of side effects are seen with M1 antagonism

A

Anticholinergic side effects
E.g.dry eyes, confusion, constipation, dry mouth, urinary retention

4 CANT’s - can’t see, can’t pee, can’t spit, can’t shit

26
Q

What type of side effects are seen with alpha1 adrenergic antagonism

A

Anti-adrenergic side effects
E.g. orthostatic hypotension, dizziness, reflex tachycardia (when blood pressure drops, HR increases)

27
Q

What type of side effects are seen with H1 antagonism

A

Antihistaminic side effects
E.g. weight gain, drowsiness

28
Q

True or false: SGA’s only block 5HT2

A

False - prefer to block 5HT2 but if no 5HT2 receptors available will block D2

29
Q

Which SGA’s are more likely to cause anticholinergic side effects due to blocking M1?

A

Clozapine & olanzapine

30
Q

Which SGA’s are more likely to cause orthostasis & dizziness due to blocking alpha1?

A

Clozapine, risperidone, paliperidone & asenapine

31
Q

Which SGA’s are more likely to cause sedation and weight gain due to blocking H1?

A

Clozapine, olanzapine and quetiapine

32
Q

What is a heteroreceptor/brake?

A

5HT receptor on dopamine neuron

33
Q

How do the presynaptic serotonin heteroreceptors affect dopamine release?

A

When endogenous 5HT binds to the heteroreceptor, DA release is inhibited

34
Q

How to SGA’s affect dopamine release?

A

SGA’s bind to the presynaptic 5HT heteroreceptor/brake and doesn’t let serotonin bind which then allows dopamine to be released

35
Q

What effect do SGA’s have on the mesocortical tract?

A

In untreated schizophrenia, there is too little DA in the mesocortical tract which results in negative symptoms. SGA will block the brake allowing dopamine to be released and improve negative symptoms

36
Q

What effect do SGA’s have on the nigrostriatal and tuberoinfundibular tracts?

A

In untreated schizophrenia, there is a normal level of dopamine in these tracts. An SGA will block the brake cause DA to be released. An increase in dopamine has no effect here so no EPS or hyper prolactin is present

37
Q

What effect do SGA’s have on the mesolimbic tract?

A

THERE ARE NO PRESYNAPTIC 5HT BRAKES IN MESOIMBIC TRACT

In untreated schizophrenia there is too much dopamine in the mesolimbic tract which causes positive symptoms. Since there is no 5HT receptor for the SGA to block, it will block D2 and inhibit release of dopamine which will improve positive symptoms

38
Q

SGA’s can block M3. What side effects can be seen because of this?

A

Impaired glucose tolerance (IGT) and T2DM

39
Q

What are the top 3 SGA offenders for metabolic side effects

A

Olanzapine, clozapine & quetiapine
* if a patient is on one of these and not gaining weight be suspicious on whether or not they are taking it

40
Q

Antagonism of which receptors are responsible for increased appetite, weight gain and dyslipidemia

A

H1 and 5-HT2c

41
Q

Antagonism of which receptor causes impaired glucose tolerance and type 2 DM

A

M3

42
Q

Based on the receptor profiles of SGAs, how can we tell whether or not a patient is more likely to experience increased appetite, weight gain and/or dyslipidemia

A

Agents that have a moderate affinity for H1 or 5-HT2c and moderate-high or high affinity for the other one are more likely to experience these problems

43
Q

This SGA has:
- high metabolic risk
- anticholinergic effects
- postural hypotension
- sedating effects
- low QT risk
- seizures and agranulocytosis

A

Clozapine

44
Q

This SGA has:
- high metabolic risk
- anticholinergic effects
- minimal postural hypotension
- sedating effects
- moderate QT risk

A

Olanzapine

45
Q

This SGA has:
- low metabolic risk
- low postural hypotension
- no anticholinergic effects
- no sedation
- needs at least 500kcal meal
- high QT risk

A

Ziprasidone

46
Q

This SGA has:
- moderate to high metabolic risk
- minimal anticholinergic effects
- minimal postural hypotension
- sedating effects
- moderate QT risk

A

Quetiapine

47
Q

This SGA has:
- moderate metabolic risk
- no anticholinergic side effects
- postural hypotension
- minimal sedation
- low to moderate QT risk
*increased risk of EPS/TD and hyperprolactemia due to high affinity for D2

A

Risperidone

48
Q

This SGA has:
- EPS - akathisia, Parkinson’s
- dose dependant sedation
- nausea
- needs at least 350 kcal

A

Lurasidone

49
Q

This SGA has:
- EPS - akathisia
- postural hypotension
- sedation
- SL administration

A

Asenapine

50
Q

This SGA has:
- dose dependant EPS
- hyperprolactemia
- some sedation
- postural hypotension
- ghost cap in stool

A

Paliperidone

51
Q

True or false: TGA’s are antagonists

A

False - partial dopamine agonists

52
Q

What effects do TGA’s have on the mesolimbic tract?

A

In untreated schizophrenia, there is too much dopamine in the mesolimbic tract which causes positive symptoms. A partial DA agonist will compete with endogenous DA for the receptors therefore it behaves kinda like an antagonists and improves positive symptoms

53
Q

What effects do TGA’s have on the mesocortical tract

A

In untreated schizophrenia, there is too little dopamine in the mesocortical tract which causes negative symptoms. A partial agonist will act as an agonist and bind to the DA receptors and increase DA transmission thus improving negative symptoms

54
Q

What effects do TGA’s have on the nigrostriatal and tuberoinfundibular tracts

A

Less risk of EPS/TD and hyperprolactemia

55
Q

This TGA has:
- low metabolic risk
- no anticholinergic effects
- minimal postural hypotension
- not sedating
- can be activating (agitation, akathisia, insomnia)

A

Aripiprzole

56
Q

This TGA is also a
- 5-HT1a partial agonist which improves mood, anxiety and cognition
- 5HT7 antagonist which helps with mood, cognitions and negative symptoms
- alpha 1 antagonist which can cause postural hypotension

May also see dose dependant akathisia

A

Brexpiprazole

57
Q

This TGA is also a
- D3 partial agonist which may have improvements on negative e symptoms?
- 5HT1a partial agonist (high affinity) which improves mood, anxiety and cognition
- presynaptic 5HT2a antagonist

*May also see dose dependant akathisia

A

Cariprazine

*Pharmacology 5815 (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions